Treated plasma cell lesions of bone with MRI signs of response to treatment: Unexpected pathological findings

Skeletal Radiology

Volumn 27, Issue 12, 1998, Pages 692-695

  Lecouvet, Frédéric E ^a   De Nayer, Pierre ^a   Garbar, Christian ^a   Noël, Henri ^a   Malghem, Jacques ^a   Maldague, Baudouin E ^a   Vande Berg, Bruno C ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Bone marrow; MRI; Plasma cell neoplasms; Treatment

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; GADOLINIUM; MELPHALAN; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; BIOPSY; BONE MARROW DISEASE; BONE MARROW TRANSPLANTATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; HISTOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMACYTOMA; PRIORITY JOURNAL;

ADULT; BONE AND BONES; BONE NEOPLASMS; CELL SURVIVAL; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NECROSIS; PLASMA CELLS; PLASMACYTOMA;

EID: 0032432944     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002560050461     Document Type: Article

References (6)

1. Moulopoulos LA, Dimopoulos MA, Alexanian R, Leeds NE, Libshitz HI. Multiple myeloma: MR patterns of re-sponse to treatment. Radiology 1994; 193:441-446.
2. Rahmouni A, Divine M, Mathieu D, Golli M, Haioun C, Dao T, Anglade MC, Reyes F, Vasile N. MR appearance of multiple myeloma of the spine before and after treatment. AJR 1993; 160:1053-1057.
3. Sze G, Bravo S, Krol G. Spinal lesions: quantitative and qualitative temporal evolution of gadopentetate dimeglumine enhancement in MR imaging. Radiology 1989; 170:849-856.
4. Salmon SE, Cassady JR. Plasma cell neoplasms. In: De Vita VT, Hellman S, Rosenberg SA (eds). Cancer: principles and practice of oncology. Philadelphia: Lippincott, 1995:1984-2024.
5. Boccadoro M, Pileri A. Diagnosis, prognosis, and standard treatment of multiple myeloma. Hematol Oncol Clin North Am 1997; 11:111-131.
6. Kovacsovics TJ, Delaly A. Intensive treatment strategies in multiple myeloma. Semin Hematol 1997; 34:49-60.